These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38346708)

  • 1. A novel nomogram for prediction of intrahepatic recurrence-free survival in patients with HCC followed by radiofrequency ablation.
    Wang B; Wu H; Wang S; Zhang ZY; Wu W; Yan K; Yang W
    Br J Radiol; 2024 Mar; 97(1156):844-849. PubMed ID: 38346708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram including chemotherapy response for prediction of intrahepatic progression-free survival in patients with colorectal liver metastasis through chemotherapy followed by radiofrequency ablation.
    Wu H; Liu GJ; Zhang ZY; Wu W; Meng YF; Wang S; Yang W; Yan K
    Int J Hyperthermia; 2021; 38(1):633-639. PubMed ID: 33882789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival.
    Yang Y; Chen Y; Ye F; Cao X; Xin Y; Wang Y; Lei Y; Li X; Feng D; Zhou X; Fan Q
    Eur Radiol; 2021 May; 31(5):3053-3064. PubMed ID: 33175203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of pan-immune-inflammation value in hepatocellular carcinoma treated by curative radiofrequency ablation: potential role for individualized adjuvant systemic treatment.
    Liang X; Bu J; Jiang Y; Zhu S; Ye Q; Deng Y; Lu W; Liu Q
    Int J Hyperthermia; 2024; 41(1):2355279. PubMed ID: 38767372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic nomogram for hepatocellular carcinoma with radiofrequency ablation: a retrospective cohort study.
    Lu Z; Sun Z; Liu C; Shi X; Li R; Shao W; Zheng Y; Li Y; Song J
    BMC Cancer; 2021 Jun; 21(1):751. PubMed ID: 34187430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When to Perform Surgical Resection or Radiofrequency Ablation for Early Hepatocellular Carcinoma?: A Nomogram-guided Treatment Strategy.
    Liu PH; Hsu CY; Lee YH; Hsia CY; Huang YH; Su CW; Chiou YY; Lin HC; Huo TI
    Medicine (Baltimore); 2015 Oct; 94(43):e1808. PubMed ID: 26512576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartate aminotransferase-to-platelet ratio index for predicting late recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Zhang X; Xin Y; Yang Y; Chen Y; Cao XJ; Wang Y; Fan Q; Zhou X; Li X
    Int J Hyperthermia; 2022; 39(1):437-445. PubMed ID: 35249443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of risk factors and construction of predictive nomogram for early recurrence after radiofrequency ablation of hepatocellular carcinoma].
    Han RC; Ma XH; Wang S; Yang Y; Feng B; Liang M; Zhao XM
    Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):546-552. PubMed ID: 34034474
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictive nomograms of repeat intrahepatic recurrence and overall survival after radiofrequency ablation of recurrent colorectal liver metastases.
    Wang JC; Jiang BB; Zhang ZY; Liu YH; Shao LJ; Wang S; Yang W; Wu W; Yan K
    Int J Hyperthermia; 2024; 41(1):2323152. PubMed ID: 38465646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
    He Q; Xiong Y; Xia P; Yang X; Yu Y; Chen Z
    Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102283. PubMed ID: 38219821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systemic Inflammation Response Index (SIRI)-Based Nomogram for Predicting the Recurrence of Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation.
    Xin Y; Zhang X; Li Y; Yang Y; Chen Y; Wang Y; Zhou X; Li X
    Cardiovasc Intervent Radiol; 2022 Jan; 45(1):43-53. PubMed ID: 34561739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
    Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
    J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study.
    Tan Y; Wang X; Ma K; Zhang L; Li J; Chen P; Zhang B
    Int J Hyperthermia; 2022; 39(1):190-199. PubMed ID: 35042449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostic Value of the Albumin to Gamma-Glutamyltransferase Ratio in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation.
    Liu W; Zhang F; Quan B; Li M; Lu S; Li J; Chen R; Yin X
    Dis Markers; 2021; 2021():3514827. PubMed ID: 34840628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.
    Ng KK; Poon RT; Lo CM; Yuen J; Tso WK; Fan ST
    J Gastrointest Surg; 2008 Jan; 12(1):183-91. PubMed ID: 17874276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.
    Zhang SW; Zhang NN; Zhu WW; Liu T; Lv JY; Jiang WT; Zhang YM; Song TQ; Zhang L; Xie Y; Zhou YH; Lu W
    Front Oncol; 2022; 12():946531. PubMed ID: 35936698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a serum tumour marker-based recurrence prediction model after radiofrequency ablation for hepatocellular carcinoma.
    Yoo J; Lee MW; Lee DH; Lee JH; Han JK
    Liver Int; 2020 May; 40(5):1189-1200. PubMed ID: 32056353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of systemic immune-inflammation index-based nomogram for early stage hepatocellular carcinoma after radiofrequency ablation.
    Xin Y; Yang Y; Liu N; Chen Y; Wang Y; Zhang X; Li X; Zhou X
    J Gastrointest Oncol; 2021 Apr; 12(2):735-750. PubMed ID: 34012662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living donor liver transplantation or hepatic resection combined with intraoperative radiofrequency ablation for Child-Pugh A hepatocellular carcinoma patient with Multifocal Tumours Meeting the University of California San Francisco (UCSF) criteria.
    Xu X; Pu X; Jiang L; Huang Y; Yan L; Yang J; Wen T; Li B; Wu H; Wang W
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):607-618. PubMed ID: 32852635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram for predicting post-therapy recurrence in BCLC A/B hepatocellular carcinoma with Child-Pugh B cirrhosis.
    Qiao W; Sheng S; Xiong Y; Han M; Jin R; Hu C
    Front Immunol; 2024; 15():1369988. PubMed ID: 38799452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.